Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Depomed, World's Loneliest Drug Firm, Signs Deal With Solvay
- Depomed, the Menlo Park, Calif., drug company that had only one Wall Street analyst on its Q3 conference call -- hello, Scott Henry of Roth Capital! -- finally has another friend. It signed a deal with Solvay Pharmaceuticals to market an extended release version of gabapentin. The deal potentially gives...
- Blog posts 2008-11-22
Additional Resources
- Depomed, Inc. Q3 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you Operator instructions. Carl Pelzel Hey, operator, why don't we open up for questions? Operator Our first question comes from Scott Henry with Roth Capital. Scott Henry – Roth Capital Thank you and good afternoon. I guess just starting with the clinical timeline expectations...
- Earnings calls 2008-11-20
- Obagi Medical Products, Inc. Q1 2009 Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions. Our first question comes from the line of Scott Henry - Roth Capital Partners. Scott Henry - Roth Capital Partners When I look at the GAAP versus non-GAAP, I just wanted to make sure where everything is coming out of. Obviously the...
- Earnings calls 2009-05-07
- Warner Chilcott Limited Q3 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you, sir. Operator Instructions And we'll take our first question from Scott Henry with Roth Capital. Scott Henry - Roth Capital Partners Thank you. Just two quick questions. First with regards to the 10 million pipeline mile stone, that I believe you will not take down....
- Earnings calls 2008-11-10
- DepoMed, Inc. Q2 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator instructions We will take our first question from Scott Henry with Roth Capital. Scott Henry – Roth Capital Thank you. Good afternoon. Congratulations again, Carl, for finding another $10 million for shareholders that we were not expecting with the Merck deal, certainly give you a lot...
- Earnings calls 2009-07-30
- DepoMed, Inc., Q1 2009 Earnings Call Transcript
- Question-and-Answer Session Operator Operator instructions We will go first to Scott Henry with Roth Capital. Scott Henry – Roth Capital I think everything is pretty straight forward this quarter. Obviously a lot of things to watch in the second half of the year, but a couple of...
- Earnings calls 2009-05-04
- Santarus Inc. Q3 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from Scott Henry - Roth Capital. Scott Henry - Roth Capital You certainly covered a lot in the prepared remarks, but just a couple of questions on the R&D side. First on Rifamycin, when do you expect to file the...
- Earnings calls 2009-11-04
- DepoMed, Inc. Q4 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you so much. Operator instructions We will go first to Scott Henry with Roth Capital. Scott Henry – Roth Capital Thank you, Carol. Just a couple specific questions and then the big picture questions. And I might have missed a couple of things, but could get...
- Earnings calls 2009-03-05
- Noven Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript
- Question-and-Answer Session Operator Operator instructions Our first question coming from Scott Henry of Roth Capital. Scott Henry – Roth Capital Thank you for taking the question. Just a couple of them. First, is there any thought on the lithium once-a-day product in terms of are you...
- Earnings calls 2008-09-12
- Matrixx Initiatives Inc. F1Q10 (Qtr End 30/06/09) Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from Scott Henry - Roth Capital. Scott Henry - Roth Capital I’d start by saying, Bill you might want to lose the acting title as far as the President, certainly given and the working you have in front of you. I...
- Earnings calls 2009-08-11
- KOS Pharmaceuticals Q2 2006 Earnings Conference Call Transcript (KOSP)
- Question-and-Answer SessionOperator [Operator Instructions]. Our first question comes from Scott Henry of Oppenheimer. Scott Henry - Oppenheimer Funds Thanks for taking the question, I just -- couple of things on a couple of different issues. First, could you update the share buy back, I know you...
- Earnings calls 2006-08-08
- Matrixx Initiatives, Inc., F4Q09 (Qtr End 03/31/09) Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from Scott Henry from Roth Capital Partners. Scott Henry - Roth Capital Partners LLC Thanks and congratulations on exceeding estimates this year in a very challenging year for the cold/flu season. First, when we look at...
- Earnings calls 2009-05-12
- Matrixx Initiatives, Inc. F2Q10 (Qtr End 09/30/09) Earnings Call Transcript
- Question-and-Answer SessionOperator Thank you. Operator Instructions. And we will take our first question from Scott Henry with Roth Capital. Scott Henry – Roth Capital Hello Bill. I guess just starting from the big picture, it seems that this quarter would at least preliminarily indicate that consumers are not afraid...
- Earnings calls 2009-10-27
- Arbitron.(appointments)(Brief Article)
- VAUGHAN SCOTT HENRY was named executive vice president, chief information officer at Arbitron Inc. He had been with Verizon Communications Inc. Also, Arbitron named SCOTT MUSGRAVE senior vice president, marketing, ... VAUGHAN SCOTT HENRY was named executive vice...
- Research articles 2005-02-14
- Outstanding Advancement in Health Care.(Focus)(Henry Ford Hospital's Scott Dulchavsky's research on portable ultrasound machines)
- Byline: Michelle Martinez Scott Dulchavsky Chair, Department of Surgery, Henry Ford Hospital; principal investigator for advanced ultrasound for NASA on the International Space Station Scott Dulchavsky gave U.S. and Russian space travelers a look at something they'd never...
- Research articles 2005-08-29
- Eli Lilly Q2 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions And our first question comes from the line of James Kelly of Goldman Sachs. Please go ahead. James Kelly - Goldman Sachs Thank you and good morning. My question relates to Zyprexa and the depot formulation, and thank you for the additional data in Canada...
- Earnings calls 2007-07-24
- Las Vegas Sands Q2 2006 Earnings Conference Call Transcript (LVS)
- Earnings Call Excerpt Las Vegas Sands, LVS Q2 2006 Earnings Conference Call August 2, 2006, 4:30 p.m. EST Executives: William Weidner, President and Chief Operating Officer Sheldon G. Adelson, Chairman Brad Stone, Executive Vice President Scott Henry, Senior Vice President ...
- Earnings calls 2006-08-02
- Profile Technologies CEO G.L. Scott & CFO Henry Gemino Discuss Commercializing Pipeline Testing Technology
- NEW YORK--BUSINESS WIRE--Nov. 11, 1998--In a recent interview, G.L. Scott & Henry Gemino of Profile Technologies (Nasdaq:PRTK) talk at length about the company's technology for inspecting pipelines for corrosion. Gemino says: "In the process of development, we've taken a technology, which is a fundamentally new one, that involves the...
- Research articles 1998-11-11
- Rugby Union: All Blacks look past Henry in hunt for coach
- JUDGING BY the circumstances surrounding Scott Gibbs' abrupt retirement from international rugby, there are number of prominent figures in Wales who would very much like to see Graham Henry lured back to his native New Zealand with a promise of the All Blacks' coaching job. The indications are that they...
- Research articles 2001-09-28
- NCAA Men's: NCAA Game Summary - Missouri-Kansas City vs. Idaho State.
- Dec 27, 2002 The Sports Network via COMTEX (Friday, December 27th) ...
- Research articles 2002-12-28
- << Previous
- page 1 of 1
- Next >>
Presented by American Express